Literature DB >> 27543965

SAG/Rbx2-Dependent Neddylation Regulates T-Cell Responses.

Nathan D Mathewson1, Hideaki Fujiwara2, Shin-Rong Wu1, Tomomi Toubai2, Katherine Oravecz-Wilson2, Yaping Sun2, Corinne Rossi2, Cynthia Zajac2, Yi Sun3, Pavan Reddy4.   

Abstract

Neddylation is a crucial post-translational modification that depends on the E3 cullin ring ligase (CRL). The E2-adapter component of the CRL, sensitive to apoptosis gene (SAG), is critical for the function of CRL-mediated ubiquitination; thus, the deletion of SAG regulates neddylation. We examined the role of SAG-dependent neddylation in T-cell-mediated immunity using multiple approaches: a novel T-cell-specific, SAG genetic knockout (KO) and chemical inhibition with small-molecule MLN4924. The KO animals were viable and showed phenotypically normal mature T-cell development. However, in vitro stimulation of KO T cells revealed significantly decreased activation, proliferation, and T-effector cytokine release, compared with WT. Using in vivo clinically relevant models of allogeneic bone marrow transplantation also demonstrated reduced proliferation and effector cytokine secretion associated with markedly reduced graft-versus-host disease. Similar in vitro and in vivo results were observed with the small-molecule inhibitor of neddylation, MLN4924. Mechanistic studies demonstrated that SAG-mediated effects in T cells were concomitant with an increase in suppressor of cytokine signaling, but not NF-κB translocation. Our studies suggest that SAG is a novel molecular target that regulates T-cell responses and that inhibiting neddylation with the clinically available small-molecule MLN4924 may represent a novel strategy to mitigate T-cell-mediated immunopathologies, such as graft-versus-host disease.
Copyright © 2016 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27543965      PMCID: PMC5222982          DOI: 10.1016/j.ajpath.2016.06.014

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  33 in total

Review 1.  Helping the CD8(+) T-cell response.

Authors:  Michael J Bevan
Journal:  Nat Rev Immunol       Date:  2004-08       Impact factor: 53.106

2.  Neddylation plays an important role in the regulation of murine and human dendritic cell function.

Authors:  Nathan Mathewson; Tomomi Toubai; Steven Kapeles; Yaping Sun; Katherine Oravecz-Wilson; Hiroya Tamaki; Ying Wang; Guoqing Hou; Yi Sun; Pavan Reddy
Journal:  Blood       Date:  2013-07-17       Impact factor: 22.113

3.  A novel positive feedback loop mediated by the docking protein Gab1 and phosphatidylinositol 3-kinase in epidermal growth factor receptor signaling.

Authors:  G A Rodrigues; M Falasca; Z Zhang; S H Ong; J Schlessinger
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

4.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

Review 5.  A new look at T cell receptor signaling to nuclear factor-κB.

Authors:  Suman Paul; Brian C Schaefer
Journal:  Trends Immunol       Date:  2013-03-07       Impact factor: 16.687

6.  RBX1/ROC1 disruption results in early embryonic lethality due to proliferation failure, partially rescued by simultaneous loss of p27.

Authors:  Mingjia Tan; Shannon W Davis; Thomas L Saunders; Yuan Zhu; Yi Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-26       Impact factor: 11.205

7.  An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer.

Authors:  Teresa A Soucy; Peter G Smith; Michael A Milhollen; Allison J Berger; James M Gavin; Sharmila Adhikari; James E Brownell; Kristine E Burke; David P Cardin; Stephen Critchley; Courtney A Cullis; Amanda Doucette; James J Garnsey; Jeffrey L Gaulin; Rachel E Gershman; Anna R Lublinsky; Alice McDonald; Hirotake Mizutani; Usha Narayanan; Edward J Olhava; Stephane Peluso; Mansoureh Rezaei; Michael D Sintchak; Tina Talreja; Michael P Thomas; Tary Traore; Stepan Vyskocil; Gabriel S Weatherhead; Jie Yu; Julie Zhang; Lawrence R Dick; Christopher F Claiborne; Mark Rolfe; Joseph B Bolen; Steven P Langston
Journal:  Nature       Date:  2009-04-09       Impact factor: 49.962

8.  Validation of SAG/RBX2/ROC2 E3 ubiquitin ligase as an anticancer and radiosensitizing target.

Authors:  Lijun Jia; Jie Yang; Xinbao Hao; Min Zheng; Hongbin He; Xiufang Xiong; Liang Xu; Yi Sun
Journal:  Clin Cancer Res       Date:  2010-01-26       Impact factor: 12.531

9.  The p21-dependent radiosensitization of human breast cancer cells by MLN4924, an investigational inhibitor of NEDD8 activating enzyme.

Authors:  Dong Yang; Mingjia Tan; Gongxian Wang; Yi Sun
Journal:  PLoS One       Date:  2012-03-22       Impact factor: 3.240

Review 10.  From bytes to bedside: data integration and computational biology for translational cancer research.

Authors:  Jomol P Mathew; Barry S Taylor; Gary D Bader; Saiju Pyarajan; Marco Antoniotti; Arul M Chinnaiyan; Chris Sander; Steven J Burakoff; Bud Mishra
Journal:  PLoS Comput Biol       Date:  2007-02-23       Impact factor: 4.475

View more
  11 in total

Review 1.  Association Between Neddylation and Immune Response.

Authors:  Jiali Zhu; Feng Chu; Meirong Zhang; Wenhuan Sun; Fangfang Zhou
Journal:  Front Cell Dev Biol       Date:  2022-05-05

2.  The Ube2m-Rbx1 neddylation-Cullin-RING-Ligase proteins are essential for the maintenance of Regulatory T cell fitness.

Authors:  Di Wu; Haomin Li; Mingwei Liu; Jun Qin; Yi Sun
Journal:  Nat Commun       Date:  2022-05-31       Impact factor: 17.694

Review 3.  Protein neddylation and its alterations in human cancers for targeted therapy.

Authors:  Lisha Zhou; Wenjuan Zhang; Yi Sun; Lijun Jia
Journal:  Cell Signal       Date:  2018-01-10       Impact factor: 4.315

4.  Cell type-specific transcriptomics identifies neddylation as a novel therapeutic target in multiple sclerosis.

Authors:  Kicheol Kim; Anne-Katrin Pröbstel; Ryan Baumann; Julia Dyckow; James Landefeld; Elva Kogl; Lohith Madireddy; Rita Loudermilk; Erica L Eggers; Sneha Singh; Stacy J Caillier; Stephen L Hauser; Bruce A C Cree; Lucas Schirmer; Michael R Wilson; Sergio E Baranzini
Journal:  Brain       Date:  2021-03-03       Impact factor: 13.501

5.  SAG/RBX2 E3 Ubiquitin Ligase Differentially Regulates Inflammatory Responses of Myeloid Cell Subsets.

Authors:  Xiufang Xiong; Nathan D Mathewson; Hua Li; Mingjia Tan; Hideaki Fujiwara; Haomin Li; Pavan Reddy; Yi Sun
Journal:  Front Immunol       Date:  2018-12-06       Impact factor: 7.561

Review 6.  Neddylation: a novel modulator of the tumor microenvironment.

Authors:  Lisha Zhou; Yanyu Jiang; Qin Luo; Lihui Li; Lijun Jia
Journal:  Mol Cancer       Date:  2019-04-03       Impact factor: 27.401

7.  Neddylation Facilitates the Antiviral Response in Zebrafish.

Authors:  Guangqing Yu; Xing Liu; Jinhua Tang; Chenxi Xu; Gang Ouyang; Wuhan Xiao
Journal:  Front Immunol       Date:  2019-06-25       Impact factor: 7.561

Review 8.  Targeting neddylation E2s: a novel therapeutic strategy in cancer.

Authors:  Yi-Chao Zheng; Yan-Jia Guo; Bo Wang; Chong Wang; M A A Mamun; Ya Gao; Hong-Min Liu
Journal:  J Hematol Oncol       Date:  2021-04-07       Impact factor: 17.388

9.  Blocking PD1/PDL1 Interactions Together with MLN4924 Therapy is a Potential Strategy for Glioma Treatment.

Authors:  Natalia Filippova; Xiuhua Yang; Zixiao An; Louis B Nabors; Larisa Pereboeva
Journal:  J Cancer Sci Ther       Date:  2018-08-06

Review 10.  Neddylation: A Versatile Pathway Takes on Chronic Liver Diseases.

Authors:  Jiping Yao; Xue Liang; Yanning Liu; Min Zheng
Journal:  Front Med (Lausanne)       Date:  2020-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.